sb 203580 has been researched along with riluzole in 3 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (riluzole) | Trials (riluzole) | Recent Studies (post-2010) (riluzole) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,244 | 153 | 572 |
Protein | Taxonomy | sb 203580 (IC50) | riluzole (IC50) |
---|---|---|---|
Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | 4.73 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 10 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.733 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.733 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Hata, Y; Ichisaka, S; Kaneko, R; Kato, K; Katoh-Semba, R; Kitajima, S; Miyazaki, N; Takahashi, Y; Tsuzuki, M; Yamada, H | 1 |
Bertz, J; Gladbach, A; Ittner, AA; Ittner, LM; Suh, LS | 1 |
3 other study(ies) available for sb 203580 and riluzole
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Activation of p38 mitogen-activated protein kinase is required for in vivo brain-derived neurotrophic factor production in the rat hippocampus.
Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Anisomycin; Brain-Derived Neurotrophic Factor; Calcium Channel Blockers; Calcium Channels, N-Type; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Hippocampus; Imidazoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Riluzole; Up-Regulation | 2009 |
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Dizocilpine Maleate; Electrodes, Implanted; Electroencephalography; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Antagonists; Gamma Rhythm; Hippocampus; Imidazoles; Male; Mice, Inbred C57BL; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, N-Methyl-D-Aspartate; Riluzole; Theta Rhythm | 2014 |